Protalix Biotherapeutics, Inc.(NYSE Amex Equities : PLX)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.48% | 166.09 | 0.7% | $1108.87m | |
| PFE | Pfizer Inc. | -0.72% | 49.75 | 0.9% | $939.86m | |
| ABBV | AbbVie, Inc. | -0.22% | 142.29 | 1.9% | $831.12m | |
| MRK | Merck & Co., Inc. | -0.47% | 90.59 | 0.7% | $806.25m | |
| LLY | Eli Lilly & Co. | 1.90% | 313.93 | 1.1% | $798.53m | |
| BMY | Bristol-Myers Squibb Co. | -1.36% | 74.54 | 1.0% | $648.45m | |
| SIGA | SIGA Technologies, Inc. | 5.66% | 26.15 | 0.0% | $514.56m | |
| AZN | AstraZeneca Plc | 0.26% | 66.81 | 1.0% | $373.58m | |
| GBT | Global Blood Therapeutics, Inc. | 0.43% | 67.04 | 5.6% | $334.64m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -1.21% | 231.01 | 8.2% | $285.62m | |
| GSK | GSK Plc | -3.08% | 34.92 | 0.3% | $275.20m | |
| HZNP | Horizon Therapeutics Plc | -3.81% | 64.90 | 5.4% | $222.52m | |
| KRTX | Karuna Therapeutics, Inc. | -1.34% | 273.71 | 0.0% | $217.12m | |
| CCXI | ChemoCentryx, Inc. | 0.18% | 50.81 | 2.9% | $205.42m | |
| RGEN | Repligen Corp. | 1.74% | 255.73 | 6.7% | $190.66m |
Company Profile
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.